NRx Pharmaceuticals (NRXP) on Wednesday announced the pricing of an underwritten public offering of 5.71M shares of its common stock, par value $0.001 per share at a public offering price of $3.50 per share of common stock.
The company has Newsletters for Every Investor Get daily, sector-specific newsletters packed with expert insights, fresh ideas, and new opportunities
Subscribe to Newsletters To ensure this doesnât happen in the future, please enable Javascript and cookies in your browser